featured
Risk Factors for MEK-Associated Retinopathy in Patients With Advanced Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Therapeutic advances in medical oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risk Factors for MEK-Associated Retinopathy in Patients With Advanced Melanoma Treated With Combination BRAF and MEK Inhibitor Therapy
Ther Adv Med Oncol 2020 Jul 31;[EPub Ahead of Print], AEC Booth, AM Hopkins, A Rowland, G Kichenadasse, JR Smith, MJ SorichFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.